Advances in clinical trial design: Weaving tomorrow's TB treatments von Lienhardt, Christian, Nunn, Andrew, Chaisson, Richard, Vernon, Andrew A, Zignol, Matteo, Nahid, Payam, Delaporte, Eric, Kasaeva, Tereza

Volltext

Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance von Lienhardt, Christian, Vernon, Andrew A, Cavaleri, Marco, Nambiar, Sumati, Nahid, Payam

Volltext

Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model von Rosenthal, Ian M, Zhang, Ming, Williams, Kathy N, Peloquin, Charles A, Tyagi, Sandeep, Vernon, Andrew A, Bishai, William R, Chaisson, Richard E, Grosset, Jacques H, Nuermberger, Eric L

Volltext

Potent Twice-Weekly Rifapentine-containing Regimens in Murine Tuberculosis von Rosenthal, Ian M, Williams, Kathy, Tyagi, Sandeep, Peloquin, Charles A, Vernon, Andrew A, Bishai, William R, Grosset, Jacques H, Nuermberger, Eric L

Volltext

Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimens von Burman, William J, Cotton, Mark F, Gibb, Diana M, Walker, A Sarah, Vernon, Andrew A, Donald, Peter R

Volltext

Isoniazid-Rifapentine for Latent Tuberculosis Infection: A Systematic Review and Meta-analysis von Njie, Gibril J., Morris, Sapna Bamrah, Woodruff, Rachel Yelk, Moro, Ruth N., Vernon, Andrew A., Borisov, Andrey S.

Volltext

Novel Regimens of Bedaquiline-Pyrazinamide Combined with Moxifloxacin, Rifabutin, Delamanid and/or OPC-167832 in Murine Tuberculosis Models von Tasneen, Rokeya, Garcia, Andrew, Converse, Paul J, Zimmerman, Matthew D, Dartois, Veronique, Kurbatova, Ekaterina, Vernon, Andrew A, Carr, Wendy, Stout, Jason E, Dooley, Kelly E, Nuermberger, Eric L

Volltext

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis von Blumberg, Henry M, Burman, William J, Chaisson, Richard E, Daley, Charles L, Etkind, Sue C, Friedman, Lloyd N, Fujiwara, Paula, Grzemska, Malgosia, Hopewell, Philip C, Iseman, Michael D, Jasmer, Robert M, Koppaka, Venkatarama, Menzies, Richard I, O'Brien, Richard J, Reves, Randall R, Reichman, Lee B, Simone, Patricia M, Starke, Jeffrey R, Vernon, Andrew A

Volltext

Health inequities among persons with disabilities: a global scoping review von Umucu, Emre, Vernon, Andrew A., Pan, Deyu, Qin, Sang, Solis, Guillermina, Campa, Rebecca, Lee, Beatrice

Volltext

In Memoriam, Fred Gordin, MD, 1951-2018 von Cohn, David L, El Sadr, Wafaa M, Abrams, Donald I, Neaton, James D, Benator, Debra A, Vernon, Andrew A

Volltext

Moxifloxacin-containing Regimens of Reduced Duration Produce a Stable Cure in Murine Tuberculosis von Nuermberger, Eric L, Yoshimatsu, Tetsuyuki, Tyagi, Sandeep, Williams, Kathy, Rosenthal, Ian, O'Brien, Richard J, Vernon, Andrew A, Chaisson, Richard E, Bishai, William R, Grosset, Jacques H

Volltext

Reinfection Redux von Vernon, Andrew A., Villarino, M. Elsa

Volltext

Weekly Moxifloxacin and Rifapentine Is More Active Than the Denver Regimen in Murine Tuberculosis von Rosenthal, Ian M, Williams, Kathy, Tyagi, Sandeep, Vernon, Andrew A, Peloquin, Charles A, Bishai, William R, Grosset, Jacques H, Nuermberger, Eric L

Volltext

Decreased plasma rifapentine concentrations associated with AADAC single nucleotide polymorphism in adults with tuberculosis von Weiner, Marc, Gelfond, Jon, Johnson-Pais, Teresa L, Engle, Melissa, Johnson, John L, Whitworth, William C, Bliven-Sizemore, Erin, Nsubuga, Pheona, Dorman, Susan E, Savic, Rada

Volltext

Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVEN... von Sterling, Timothy R., Moro, Ruth N., Borisov, Andrey S., Phillips, Elizabeth, Shepherd, Gillian, Adkinson, Newton Franklin, Weis, Stephen, Ho, Christine, Villarino, Margarita Elsa

Volltext

In the treatment of tuberculosis, you get what you pay for von Vernon, Andrew A, Iademarco, Michael F

Volltext

Clinical Evaluation of the Nelfinavir-Rifabutin Interaction in Patients with Tuberculosis and Human Immunodeficiency Virus Infection von Benator, Debra A., Weiner, Marc H., Burman, William J., Vernon, Andrew A., Zhao, Zhen A., Khan, Awal E., Jones, Brenda E., Sandman, Laurie, Engle, Melissa, Silva-Trigo, Claudia, Hsyu, Poe H., Becker, Mark I., Peloquin, Charles A.

Volltext

Simplifying TB Treatment von Vernon, Andrew A

Volltext bestellen

Commentary: Can capture-recapture analysis of epidemiological and molecular data help us understand recent tuberculosis transmission? von Vernon, Andrew A, McNabb, M Scott

Volltext

Current Standard Treatment von Vernon, Andrew A.

Volltext